NWNeil Watson

Neil Watson

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Neil Watson has a total of 55 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Development and evaluation of a complex ePrescribing-based Antimicrobial Stewardship (ePAMS+) intervention for hospitals: a mixed method study

    by Aziz Sheikh, Jamie Coleman, Antony Chuter, Jillian Beggs, Richard Lilford, Ann Slee, Kathrin Cresswell, Sarah Slight, Hajar Mozaffar, Sarah Pontefract, et al.

    Aims: To develop, assess the feasibility and test the effectiveness and cost-effectiveness of a multifaceted ePrescribing-based Antimicrobial Stewardship intervention to safely reduce inappropriate antibiotic use in adult medical inpatient settings. Methods: We undertook a mixed-methods programme of work organised into four interlinked work packages: Work package 1: (a) planning, developing and optimising all elements of ePrescribing-based Antimicrobial Stewardship; and (b) carrying out qualitative, feasibility and process studies of ePrescribing-based Antimicrobial Stewardship implementation. Work package 2: agreeing secondary outcome measures through an expert consensus building workshop, developing the methods to collect outcome data and establishing the feasibility of evaluating ePrescribing-based Antimicrobial Stewardship through a hybrid cluster-randomised stepped-wedge trial. Work package 3: evaluating the effectiveness of ePrescribing-based Antimicrobial Stewardship in achieving our coprimary outcomes of reducing antibiotic consumption without any adverse impact on 30-day mortality through piloting and undertaking a formal evaluation. Work package 4: estimating the cost-effectiveness of ePrescribing-based Antimicrobial Stewardship, including cost-minimisation and sensitivity analyses through evidence synthesis and expert engagement. Our research (which started on 1 January 2019) was majorly disrupted by the COVID-19 pandemic, with members of the team being redeployed to clinical and government advisory roles, and limited opportunities to undertake hospital fieldwork compounded by strikes. These delays resulted in our trial plans being pushed back by ≈ 3 years, by which time it was no longer possible to recruit sufficient numbers of hospitals into the planned definitive trial. Following discussion with the funders, we aborted plans to run the pilot and definitive trials, replacing this with qualitative scoping work to understand the ways in which trusts had innovated in the intervening period to promote antimicrobial stewardship (work package 5). Results: We developed the ePrescribing-based Antimicrobial Stewardship intervention, comprising technical, educational and behavioural components and were able to agree secondary outcome measures and the cost-effectiveness model. The feasibility trial was undertaken in two hospitals in one trust, studying 24,884 antibiotic orders on 1958 admissions. This demonstrated that several aspects of the intervention were deliverable and that we were able to extract data on 20/43 outcome measures. Modelling of the coprimary outcomes, total antibiotic defined daily dose per admission, was feasible and enabled its variability to be estimated to support further research planning. There was, however, limited engagement of clinical staff with the training element of the intervention, which was initially only voluntary. Given the severe delays, many trusts had begun implementing their own approaches to deal with growing challenge of antimicrobial stewardship. As such, we were unable to find sufficient naive sites to progress the trial. Our additional qualitative scoping work identified the myriad ways in which trusts were attempting to respond to antimicrobial stewardship. These included order sets and order protocols, default durations, alerts for review, incorporation of guidelines, and audit and feedback functionality. Limitations: We identify five key limitations: (1) the COVID-19 pandemic caused major delays, and non-COVID research activities had a lower priority than front-line clinical work and COVID-related research. The timescale for the development work is, therefore, unlikely to be representative of the time it should take to develop an intervention of this scope outside of pandemic contexts. (2) Although there was considerable stakeholder input into the development of ePrescribing-based Antimicrobial Stewardship, this did not include the entire potential user population. Nurses were under-represented. Although not directly involved in prescribing, more engagement with nurses would have been useful because they were involved in medication management workflows. (3) Undertaking the work in one trust limits generalisability, although inclusion of several ward types should help ensure that our findings related to a breadth of clinical contexts. (4) Implementation of ePrescribing-based Antimicrobial Stewardship within Cerner Millennium (North Kansas City, Missouri, USA) means feasibility in other systems still needs to be established. (5) The add-on study of antimicrobial stewardship practices included views of antimicrobial stewardship pharmacists and consultant microbiologists but did not include all hospitals nor ward prescribers. Nonetheless, this study provided many valuable insights into approaches, including the need for development of evidence for different practices. Conclusions: We developed ePrescribing-based Antimicrobial Stewardship and conducted a feasibility trial of this in inpatient settings. This development and feasibility work was, however, undertaken during challenging circumstances resulting from a combination of the COVID-19 pandemic and National Health Service pressures, making it difficult for clinicians to fully engage. Delays with our work resulted in provisionally recruited trusts innovating in relation to antimicrobial stewardship such that it was no longer possible to deliver the planned follow-on pilot and definitive trials. In summary, ePrescribing-based Antimicrobial Stewardship is, in its present format, not suitable for use in National Health Service hospitals. Future work: Hospitals are currently pursuing a range of approaches in an attempt to promote antimicrobial stewardship. There is a need to develop a typology of these approaches and establish the strength of the underpinning evidence using naturalistic designs. Trial registration: This trial is registered as ISRCTN13429325. Funding: This award was funded by the National Institute for Health and Care Research (NIHR) Programme Grants for Applied Research Programme (NIHR award ref: RP-PG-0617-20009) and is published in full in Programme Grants for Applied Research ; Vol. 14, No. 12. See the NIHR Funding and Awards website for further award information.

  • Open Access

    Complex Hospital-Based Electronic Prescribing–Based Intervention to Support Antimicrobial Stewardship: Qualitative Study

    by Kathrin Cresswell, Susan Hinder, Aziz Sheikh, Neil Watson, David Price, Andrew Heed, Sarah Katie Pontefract, Jamie Coleman, Jillian Beggs, Antony Chuter, et al.

    Background: Antimicrobial resistance (AMR) represents a growing concern for public health. Objective: We sought to explore the challenges associated with development and implementation of a complex intervention designed to improve AMS in hospitals. Methods: We conducted a qualitative evaluation of a complex AMS intervention with educational, behavioral, and technological components in 5 wards of an English hospital. At 2 weeks and 7 weeks after initiating the intervention, we interviewed 25 users of the intervention, including senior and junior prescribers, a senior nurse, a pharmacist, and a microbiologist. Topics discussed included perceived impacts of different elements of the intervention and facilitators and barriers to effective use. Interviews were supplemented by 2 observations of ward rounds to gain insights into AMS practices. Data were audio-recorded, transcribed, and inductively and deductively analyzed thematically using NVivo12. Results: Tracing the adoption and impact of the various components of the intervention was difficult, as it had been introduced into a setting with competing pressures. These particularly affected behavioral and educational components (eg, training, awareness-building activities), which were often delivered ad hoc. We found that the participatory intervention design had addressed typical use cases but had not catered for edge cases that only became visible when the intervention was delivered in real-world settings (eg, variations in prescribing workflows across different specialties and conditions). Conclusions: Effective user-focused design of complex interventions to promote AMS can support acceptance and use. However, not all requirements and potential barriers to use can be fully anticipated or tested in advance of full implementation in real-world settings.


  • Open Access

    Complex Hospital-Based Electronic Prescribing–Based Intervention to Support Antimicrobial Stewardship: Qualitative Study (Preprint)

    by Kathrin Cresswell, Susan Hinder, Aziz Sheikh, Neil Watson, David Price, Andrew Heed, Sarah Katie Pontefract, Jamie Coleman, Jillian Beggs, Antony Chuter, et al.

    BACKGROUND Antimicrobial resistance (AMR) represents a growing concern for public health. OBJECTIVE We sought to explore the challenges associated with development and implementation of a complex intervention designed to improve AMS in hospitals. METHODS We conducted a qualitative evaluation of a complex AMS intervention with educational, behavioral, and technological components in 5 wards of an English hospital. At 2 weeks and 7 weeks after initiating the intervention, we interviewed 25 users of the intervention, including senior and junior prescribers, a senior nurse, a pharmacist, and a microbiologist. Topics discussed included perceived impacts of different elements of the intervention and facilitators and barriers to effective use. Interviews were supplemented by 2 observations of ward rounds to gain insights into AMS practices. Data were audio-recorded, transcribed, and inductively and deductively analyzed thematically using NVivo12. RESULTS Tracing the adoption and impact of the various components of the intervention was difficult, as it had been introduced into a setting with competing pressures. These particularly affected behavioral and educational components (eg, training, awareness-building activities), which were often delivered ad hoc. We found that the participatory intervention design had addressed typical use cases but had not catered for edge cases that only became visible when the intervention was delivered in real-world settings (eg, variations in prescribing workflows across different specialties and conditions). CONCLUSIONS Effective user-focused design of complex interventions to promote AMS can support acceptance and use. However, not all requirements and potential barriers to use can be fully anticipated or tested in advance of full implementation in real-world settings.

  • Open Access

    ePrescribing-Based Antimicrobial Stewardship Practices in an English National Health Service Hospital: Qualitative Interview Study Among Medical Prescribers and Pharmacists

    by Kathrin Cresswell, Susan Hinder, Aziz Sheikh, Sarah Pontefract, Neil W Watson, David Price, Andrew Heed, Jamie Coleman, Holly Ennis, Jillian Beggs, et al.

    Background: Antimicrobial resistance, the ability of microorganisms to survive antimicrobial drugs, is a public health emergency. Although electronic prescribing (ePrescribing)–based interventions designed to reduce unnecessary antimicrobial usage exist, these often do not integrate effectively with existing workflows. As a result, ePrescribing-based interventions may have limited impact in addressing antimicrobial resistance. Objective: We sought to understand the existing ePrescribing-based antimicrobial stewardship (AMS) practices in an English hospital preceding the implementation of functionality designed to improve AMS. Methods: We conducted 18 semistructured interviews with medical prescribers and pharmacists with varying levels of seniority exploring current AMS practices and investigating potential areas for improvement. Participants were recruited with the help of local gatekeepers. Topic guides sought to explore both formal and informal practices surrounding AMS, and challenges and opportunities for ePrescribing-based intervention. We coded audio-recorded and transcribed data with the help of the Technology, People, Organizations, and Macroenvironmental factors framework, allowing emerging themes to be added inductively. We used NVivo 12 (QSR International) to facilitate coding. Results: Antimicrobial prescribing and review processes were characterized by competing priorities and uncertainty of prescribers and reviewers around prescribing decisions. For example, medical prescribers often had to face trade-offs between individual patient benefit and more diffuse population health benefits, and the rationale for prescribing decisions was not always clear. Prescribing involved a complex set of activities carried out by various health care practitioners who each only had a partial and temporary view of the whole process, and whose relationships were characterized by deeply engrained hierarchies that shaped interactions and varied across specialties. For example, newly qualified doctors and pharmacists were hesitant to change a consultant’s prescribing decision when reviewing prescriptions. Multidisciplinary communication, collaboration, and coordination promoted good AMS practices by reducing uncertainty. Conclusions: Design of ePrescribing-based interventions to improve AMS needs to take into account the multitude of actors and organizational complexities involved in the prescribing and review processes. Interventions that help reduce prescriber or reviewer uncertainty and improve multidisciplinary collaboration surrounding initial antimicrobial prescribing and subsequent prescription review are most likely to be effective. Without such attention, interventions are unlikely to fulfill their goal of improving patient outcomes and combatting antimicrobial resistance.


  • Open Access

    Barriers and Opportunities for the Use of Digital Tools in Medicines Optimization Across the Interfaces of Care: Stakeholder Interviews in the United Kingdom

    by Clare Tolley, Helen Seymour, Neil Watson, Hamde Nazar, Jude Heed, Dave Belshaw

    Background: People with long-term conditions frequently transition between care settings that require information about a patient’s medicines to be transferred or translated between systems. This process is currently error prone and associated with unintentional changes to medications and miscommunication, which can lead to serious patient consequences. One study estimated that approximately 250,000 serious medication errors occur in England when a patient transitions from hospital to home. Digital tools can equip health care professionals with the right information at the right time and place to support practice. Objective: This study aimed to answer the following questions: what systems are being used to transfer information across interfaces of care within a region of England? and what are the challenges and potential opportunities for more effective cross-sector working to support medicines optimization? Methods: A team of researchers at Newcastle University conducted a qualitative study by performing in-depth semistructured interviews with 23 key stakeholders in medicines optimization and IT between January and March 2022. The interviews lasted for approximately 1 hour. The interviews and field notes were transcribed and analyzed using the framework approach. The themes were discussed, refined, and applied systematically to the data set. Member checking was also performed. Results: This study revealed themes and subthemes pertaining to 3 key areas: transfer of care issues, challenges of digital tools, and future hopes and opportunities. We identified a major complexity in terms of the number of different medicine management systems used throughout the region. There were also important challenges owing to incomplete patient records. We also highlighted the barriers related to using multiple systems and their subsequent impact on user workflow, a lack of interoperability between systems, gaps in the availability of digital data, and poor IT and change management. Finally, participants described their hopes and opportunities for the future provision of medicines optimization services, and there was a clear need for a patient-centered consolidated integrated health record for use by all health and care professionals across different sectors, bridging those working in primary, secondary, and social care. Conclusions: The effectiveness and utility of shared records depend on the data within; therefore, health care and digital leaders must support and strongly encourage the adoption of established and approved digital information standards. Specific priorities regarding understanding of the vision for pharmacy services and supporting this with appropriate funding arrangements and strategic planning of the workforce were also described. In addition, the following were identified as key enablers to harness the benefits of digital tools to support future medicines optimization: development of minimal system requirements; enhanced IT system management to reduce unnecessary repetition; and importantly, meaningful and continued collaboration with clinical and IT stakeholders to optimize systems and share good practices across care sectors.


  • Open Access

    Barriers and Opportunities for the Use of Digital Tools in Medicines Optimization Across the Interfaces of Care: Stakeholder Interviews in the United Kingdom (Preprint)

    by Clare Tolley, Helen Seymour, Neil Watson, Hamde Nazar, Jude Heed, Dave Belshaw

    BACKGROUND People with long-term conditions frequently transition between care settings that require information about a patient’s medicines to be transferred or translated between systems. This process is currently error prone and associated with unintentional changes to medications and miscommunication, which can lead to serious patient consequences. One study estimated that approximately 250,000 serious medication errors occur in England when a patient transitions from hospital to home. Digital tools can equip health care professionals with the right information at the right time and place to support practice. OBJECTIVE This study aimed to answer the following questions: what systems are being used to transfer information across interfaces of care within a region of England? and what are the challenges and potential opportunities for more effective cross-sector working to support medicines optimization? METHODS A team of researchers at Newcastle University conducted a qualitative study by performing in-depth semistructured interviews with 23 key stakeholders in medicines optimization and IT between January and March 2022. The interviews lasted for approximately 1 hour. The interviews and field notes were transcribed and analyzed using the framework approach. The themes were discussed, refined, and applied systematically to the data set. Member checking was also performed. RESULTS This study revealed themes and subthemes pertaining to 3 key areas: transfer of care issues, challenges of digital tools, and future hopes and opportunities. We identified a major complexity in terms of the number of different medicine management systems used throughout the region. There were also important challenges owing to incomplete patient records. We also highlighted the barriers related to using multiple systems and their subsequent impact on user workflow, a lack of interoperability between systems, gaps in the availability of digital data, and poor IT and change management. Finally, participants described their hopes and opportunities for the future provision of medicines optimization services, and there was a clear need for a patient-centered consolidated integrated health record for use by all health and care professionals across different sectors, bridging those working in primary, secondary, and social care. CONCLUSIONS The effectiveness and utility of shared records depend on the data within; therefore, health care and digital leaders must support and strongly encourage the adoption of established and approved digital information standards. Specific priorities regarding understanding of the vision for pharmacy services and supporting this with appropriate funding arrangements and strategic planning of the workforce were also described. In addition, the following were identified as key enablers to harness the benefits of digital tools to support future medicines optimization: development of minimal system requirements; enhanced IT system management to reduce unnecessary repetition; and importantly, meaningful and continued collaboration with clinical and IT stakeholders to optimize systems and share good practices across care sectors.

  • Electronic prescribing systems in hospitals to improve medication safety: a multimethods research programme

    by Aziz Sheikh, Jamie Coleman, Antony Chuter, Robin Williams, Richard Lilford, Ann Slee, Zoe Morrison, Kathrin Cresswell, Ann Robertson, Sarah Slight, et al.

    Background: There is a need to identify approaches to reduce medication errors. Interest has converged on ePrescribing systems that incorporate computerised provider order entry and clinical decision support functionality. Objectives: We sought to describe the procurement, implementation and adoption of basic and advanced ePrescribing systems; to estimate their effectiveness and cost-effectiveness; and to develop a toolkit for system integration into hospitals incorporating implications for practice from our research. Design: We undertook a theoretically informed, mixed-methods, context-rich, naturalistic evaluation. Setting: We undertook six longitudinal case studies in four hospitals (sites C, E, J and K) that did not have ePrescribing systems at the start of the programme (three of which went live and one that never went live) and two hospitals (sites A and D) with embedded systems. In the three hospitals that implemented systems, we conducted interviews pre implementation, shortly after roll-out and at 1 year post implementation. In the hospitals that had embedded systems, we conducted two rounds of interviews, 18 months apart. We undertook a three-round eDelphi exercise involving 20 experts to identify 80 clinically important prescribing errors, which were developed into the Investigate Medication Prescribing Accuracy for Critical error Types (IMPACT) tool. We elicited the cost of an ePrescribing system at one (non-study) site and compared this with the calculated ‘headroom’ (the upper limit that the decision-maker should pay) for the systems (sites J, K and S) for which effectiveness estimates were available. We organised four national conferences and five expert round-table discussions to contextualise and disseminate our findings. Intervention: The implementation of ePrescribing systems with either computerised provider order entry or clinical decision support functionality. Main outcome measures: Error rates were calculated using the IMPACT tool, with changes over time represented as ratios of error rates (as a proportion of opportunities for errors) using Poisson regression analyses. Results: We conducted 242 interviews and 32.5 hours of observations and collected 55 documents across six case studies. Implementation was difficult, particularly in relation to integration and interfacing between systems. Much of the clinical decision support functionality in embedded sites remained switched off because of concerns about over alerting. Getting systems operational meant that little attention was devoted to system optimisation or secondary uses of data. The prescriptions of 1244 patients were audited pre computerised provider order entry and 1178 post computerised provider order entry implementation of system A at sites J and K, and system B at site S. A total of 21,138 opportunities for error were identified from 28,526 prescriptions. Across the three sites, for those prescriptions for which opportunities for error were identified, the error rate was found to reduce significantly post computerised provider order entry implementation, from 5.0% to 4.0% (p < 0.001). Post implementation, the overall proportion of errors (per opportunity) decreased significantly in sites J and S, but remained similar in site K, as follows: 4.3% to 2.8%, 7.4% to 4.4% and 4.0% to 4.4%, respectively. Clinical decision support implementation by error type was found to differ significantly between sites, ranging from 0% to 88% across clinical contraindication, dose/frequency, drug interactions and other error types (p < 0.001). Overall, 43 out of 78 (55%) of the errors had some degree of clinical decision support implemented in at least one of the hospitals. For the site in which no improvement was detected in prescribing errors (i.e. site K), the ePrescribing system represented a cost to the service for no countervailing benefit. Cost-effectiveness rose in proportion to reductions in error rates observed in the other sites (i.e. sites J and S). When a threshold value of £20,000 was used to define the opportunity cost, the system would need to cost less than £4.31 per patient per year, even in site S, where effectiveness was greatest. We produced an ePrescribing toolkit (now recommended for use by NHS England) that spans the ePrescribing life cycle from conception to system optimisation. Limitations: Implementation delays meant that we were unable to employ the planned stepped-wedge design and that the assessment of longer-term consequences of ePrescribing systems was impaired. We planned to identify the complexity of ePrescribing implementation in a number of contrasting environments, but the small number of sites means that we have to infer findings from this programme with considerable care. The lack of transparency regarding system costs is a limitation of our method. As with all health economic analyses, our analysis is subject to modelling assumptions. The research was undertaken in a modest number of early adopters, concentrated on high-risk prescribing errors and may not be generalisable to other hospitals. Conclusions: The implementation of ePrescribing systems was challenging. However, when fully implemented the ePrescribing systems were associated with a reduction in clinically important prescribing errors and our model suggests that such an effect is likely to be more cost-effective when clinical decision support is available. Careful system configuration considering clinical processes and workflows is important to achieving these potential benefits and, therefore, our findings may not be generalisable to all system implementations. Future work: Formative and summative evaluations of efforts will be central to promote learning across settings. Other priorities emerging from this work include the possibility of learning from international experiences and the commercial sector. Funding: This project was funded by the National Institute for Health and Care Research (NIHR) Programme Grants for Applied Research programme and will be published in full in Programme Grants for Applied Research; Vol. 10, No. 7. See the NIHR Journals Library website for further project information.


  • Open Access

    ePrescribing-Based Antimicrobial Stewardship Practices in an English National Health Service Hospital: Qualitative Interview Study Among Medical Prescribers and Pharmacists (Preprint)

    by Kathrin Cresswell, Susan Hinder, Aziz Sheikh, Sarah Pontefract, Neil W Watson, David Price, Andrew Heed, Jamie Coleman, Holly Ennis, Jillian Beggs, et al.

    BACKGROUND Antimicrobial resistance, the ability of microorganisms to survive antimicrobial drugs, is a public health emergency. Although electronic prescribing (ePrescribing)–based interventions designed to reduce unnecessary antimicrobial usage exist, these often do not integrate effectively with existing workflows. As a result, ePrescribing-based interventions may have limited impact in addressing antimicrobial resistance. OBJECTIVE We sought to understand the existing ePrescribing-based antimicrobial stewardship (AMS) practices in an English hospital preceding the implementation of functionality designed to improve AMS. METHODS We conducted 18 semistructured interviews with medical prescribers and pharmacists with varying levels of seniority exploring current AMS practices and investigating potential areas for improvement. Participants were recruited with the help of local gatekeepers. Topic guides sought to explore both formal and informal practices surrounding AMS, and challenges and opportunities for ePrescribing-based intervention. We coded audio-recorded and transcribed data with the help of the Technology, People, Organizations, and Macroenvironmental factors framework, allowing emerging themes to be added inductively. We used NVivo 12 (QSR International) to facilitate coding. RESULTS Antimicrobial prescribing and review processes were characterized by competing priorities and uncertainty of prescribers and reviewers around prescribing decisions. For example, medical prescribers often had to face trade-offs between individual patient benefit and more diffuse population health benefits, and the rationale for prescribing decisions was not always clear. Prescribing involved a complex set of activities carried out by various health care practitioners who each only had a partial and temporary view of the whole process, and whose relationships were characterized by deeply engrained hierarchies that shaped interactions and varied across specialties. For example, newly qualified doctors and pharmacists were hesitant to change a consultant’s prescribing decision when reviewing prescriptions. Multidisciplinary communication, collaboration, and coordination promoted good AMS practices by reducing uncertainty. CONCLUSIONS Design of ePrescribing-based interventions to improve AMS needs to take into account the multitude of actors and organizational complexities involved in the prescribing and review processes. Interventions that help reduce prescriber or reviewer uncertainty and improve multidisciplinary collaboration surrounding initial antimicrobial prescribing and subsequent prescription review are most likely to be effective. Without such attention, interventions are unlikely to fulfill their goal of improving patient outcomes and combatting antimicrobial resistance.

  • Open Access

    Medication errors and adverse drug events in a UK hospital during the optimisation of electronic prescriptions: a prospective observational study

    by Sarah P Slight, Clare L Tolley, David W Bates, Rachel Fraser, Theophile Bigirumurame, Adetayo Kasim, Konstantinos Balaskonis, Steven Narrie, Andrew Heed, E John Orav, et al.


  • Open Access

    Consensus methodology to investigate appropriate referral criteria for inpatients to be offered a transfer of care service as they are discharged home

    by Hamde Nazar, Gregory Maniatopoulos, Efi Mantzourani, Neil Watson

    Consensus methodology to investigate appropriate referral criteria for inpatients to be offered a transfer of care service as they are discharged home Hamde Nazar,1 Gregory Maniatopoulos,2 Efi Mantzourani,3 Neil Watson41School of Pharmacy, Newcastle University, Newcastle upon Tyne, UK; 2Institute of Health and Society, Newcastle University, Newcastle upon Tyne, UK; 3School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, Wales, UK; 4Pharmacy Services, Royal Victoria Infirmary NHS Hospital Trust, Newcastle upon Tyne, UK An emerging clinical role for community pharmacists is to become actively involved in the follow-up care of patients who are discharged back into the community (transfer of care services) by promoting better medication adherence and by contributing to the safe, effective, and efficient use of medication.1 Recent research highlights how this extended role of community pharmacists could help to reduce drug-related adverse events, unnecessary health provider visits, hospitalizations, and readmissions while strengthening integrated primary care delivery across the healthcare system.1,2